Contrast-enhanced 3d-mra of the upper abdomen with a bolus-injectable spio (sh u 555 a)

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 1, 1999, Pages 65-71

  Reimer, Peter ^a   Allkemper, Thomas ^a   Matuszewski, Lars ^a   Balzer, Thomas ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Abdomen; Aorta; Liver; MR angiography; SPIO; Spleen

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ABDOMEN; ABDOMINAL AORTA; ADULT; ARTICLE; BOLUS INJECTION; BREATH HOLDING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INFERIOR CAVA VEIN; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PORTAL VEIN; PRIORITY JOURNAL; SPLEEN; THREE DIMENSIONAL IMAGING;

ABDOMEN; AORTA; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OXIDES; PORTAL SYSTEM; SPLEEN;

EID: 0032783864     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199907)10:1<65::AID-JMRI9>3.0.CO;2-0     Document Type: Article

References (28)

1. Prince M, Yucel EK, Kaufman JA, Harrison DC, Geller SC. Dynamic gadolinium-enhanced 3DFT abdominal MR arteriography. J Magn Reson Imaging 1993;3:877-881.
2. Leung DA, McKinnon GC, Davis CP, Pfammatter T, Krestin GP, Debatin JF. Breath-hold, contrast-enhanced, three-dimensional MR angiography. Radiology 1996;200:569-571.
3. Adam G, Neuerburg J, Spuntrup E, Muhler A, Scherer K, Günther RW. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinlum-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer. Magn Reson Med 1994;32:622-628.
4. Wang SC, Wikstrom MG, White DL, et al. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. Radiology 1990;175:483-488.
5. McLachlan SJ, Morris MR, Lucas MA, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging 1994;4:301-307.
6. Mayo-Smith WW, Saini S, Slater G, Kaufman JA, Sharma P, Hahn PF. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. AJR 1996;166:73-77.
7. Grist TM, Korosec FR, Peters DC, et al. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998;207:539-544.
8. Bogdanov AA Jr, Weissleder R, Frank H W, et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology 1993;187:701-706.
9. Weissleder R, Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 1994;193:593-595.
10. Duda SH, Laniado M, Kopp AF, et al. Superparamagnetic iron oxide: Detection of focal liver lesions at high-field-strength MR imaging. J Magn Reson Imaging 1994;4:309-314.
11. Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995;196:481-488.
12. Harisinghani MG, Saini S, Weissleder R, et al. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent code-7227. Radiology 1997;202:687-691.
13. Weissleder R, Elizondo G, Wittenberg J, Rabito C, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide (USPIO): characterization of a new class of MR contrast agents. Radiology 1990;175:489-493.
14. Hamm B, Staks T, Taupitz M, et al. Contrast enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging 1994;4:659-668.
15. Reimer P, Rummeny EJ, Daldrup HE, et al. Clinical results with Resovist: a phase 2 clinical trial. Radiology 1995;195:489-496.
16. Reimer P, Marx C, Rummeny EJ, et al. SPIO-enhanced 2D-TOF MR-angiography of the portal venous system: results of an intraindividual comparison. J Magn Reson Imaging 1997;7:945-949.
17. Schmiedl U, Ogan M, Paajanen H, et al. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 1987;162: 205-210.
18. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991;22:282-287.
19. Weissleder R, Bogdanov A, Neuwelt E, Papisov M. Long-circulating iron oxides for MR imaging. In: Torchilin V, et al., editors. Advanced drug delivery reviews. CRC Press; 1995. p 321-334.
20. Harisinghani MG, Saini S, Slater GJ, Schnall MD, Rifkin MD. MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. J Magn Reson Imaging 1997;7:161-163.
21. Seneterre ES, Weissleder R, Jaramillo D, et al. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology 1991;179:529-533.
22. Desser TS, Rubin DL, Muller HH, et al. Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight. J Magn Reson Imaging 1994;4:467-472.
23. Adam G, Neuerburg J, Spuntrup E, Muhler A, Scherer K, Günther RW. Gd-DTPA-cascade-polymer: potential blood pool contrast agent for MR imaging. J Magn Reson Imaging 1994;4:462-466.
24. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumintargeted contrast agent for MR angiography. Radiology 1998;207: 529-538.
25. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032:89-118.
26. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
27. Hulka C, Edmister WB, Smith BL, et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997;205:837-842.
28. Moore A, Weissleder R, Bogdanov A Jr. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging 1997;7:1140-1145.